Mutagenic activity of tryptophan metabolites produced by rat intestinal microflora.
The catabolism of tryptophan by rat intestinal microflora was studied for the production of mutagenic metabolites that might be involved in the etiology of colon cancer. Various tryptophan metabolites were assayed for mutagenic and comutagenic activity in the Ames bacterial test system. These included metabolites that were identified by thin-layer chromatography in cultures of rat fecal bacteria, other compounds structurally related to tryptophan, whole unfractionated mixed fecal bacteria culture filtrates, and concentrated solvent extracts. A total of 27 materials were tested with 5 Salmonella strains in the mutagenesis assay. Most substances were inactive, and only one compound, o-aminoacetophenone, which was unlikely to be produced in the intestine, showed weak comutagenic activity. Our results did not support the hypothesis that tryptophan metabolites produced by intestinal microflora are major etiologic factors in cancer of the colon.
D000098:Acetophenones / Q000494:pharmacology; D000818:Animals; D002273:Carcinogens; D004032:Diet; D004357:Drug Synergism; D005243:Feces / Q000382:microbiology; D007210:Indoleacetic Acids / Q000378:metabolism; D007211:Indoles / Q000378:metabolism; D007413:Intestinal Mucosa / Q000378:metabolism; D007414:Intestinal Neoplasms / Q000209:etiology; D007422:Intestines / Q000382:microbiology*; D008460:Meat; D009153:Mutagens; D051381:Rats; D012486:Salmonella typhimurium / Q000187:drug effects; D014364:Tryptophan / Q000378:metabolism* / Q000633:toxicity
D000098:Acetophenones; D002273:Carcinogens; D007210:Indoleacetic Acids; D007211:Indoles; D009153:Mutagens; D014364:Tryptophan